Total Payments
$335,530
2022 Payments
$42,057
Companies
12
Transactions
58
Medicare Patients
1,268
Medicare Billing
$130,798
Payment Breakdown by Category
Royalty/License$187,190 (55.8%)
Other$67,153 (20.0%)
Consulting$50,000 (14.9%)
Food & Beverage$31,174 (9.3%)
Education$12.70 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $187,190 | 23 | 55.8% |
| Current or prospective ownership or investment interest | $67,153 | 7 | 20.0% |
| Consulting Fee | $50,000 | 5 | 14.9% |
| Food and Beverage | $31,174 | 22 | 9.3% |
| Education | $12.70 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PARI Respiratory Equipment, Inc. | $254,343 | 30 | $0 (2022) |
| Crosstex International Inc. | $80,000 | 8 | $0 (2018) |
| Genentech USA, Inc. | $418.18 | 5 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $389.93 | 5 | $0 (2019) |
| Insmed, Inc. | $135.42 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $88.89 | 1 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $31.40 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $30.63 | 2 | $0 (2019) |
| Cumberland Pharmaceuticals, Inc. | $24.52 | 2 | $0 (2021) |
| GENZYME CORPORATION | $23.38 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $42,057 | 7 | PARI Respiratory Equipment, Inc. ($42,033) |
| 2021 | $47,420 | 8 | PARI Respiratory Equipment, Inc. ($47,407) |
| 2020 | $39,009 | 8 | PARI Respiratory Equipment, Inc. ($38,954) |
| 2019 | $59,635 | 17 | PARI Respiratory Equipment, Inc. ($58,796) |
| 2018 | $107,398 | 13 | PARI RESPIRATORY EQUIPMENT, INC. ($67,153) |
| 2017 | $40,012 | 5 | Crosstex International Inc. ($40,000) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2022 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $52.44 | General |
| 10/27/2022 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $1,219.05 | General |
| 10/20/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Immunology | ||||||
| 07/13/2022 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $10,766.13 | General |
| 04/13/2022 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $9,058.50 | General |
| 03/11/2022 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $8,364.00 | General |
| 01/12/2022 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $12,573.00 | General |
| 12/31/2021 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $12,573.00 | General |
| 10/11/2021 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $1,216.66 | General |
| 09/30/2021 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $11,713.75 | General |
| 06/30/2021 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $7,161.90 | General |
| 06/28/2021 | Cumberland Pharmaceuticals, Inc. | CALDOLOR (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: ANESTHESIOLOGY PAIN MANAGEMENT | ||||||
| 05/24/2021 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $8,334.00 | General |
| 04/08/2021 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $1,219.84 | General |
| 03/31/2021 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $5,187.67 | General |
| 12/31/2020 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $5,376.85 | General |
| 10/07/2020 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $1,154.95 | General |
| 09/30/2020 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $4,571.18 | General |
| 06/30/2020 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $8,460.61 | General |
| 05/21/2020 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $1,133.58 | General |
| 03/31/2020 | PARI Respiratory Equipment, Inc. | — | Royalty or License | Cash or cash equivalent | $18,257.23 | General |
| 02/26/2020 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: IMMUNOLOGY | ||||||
| 01/22/2020 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: RESPIRATORY | ||||||
| 11/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $88.89 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 281 | 327 | $103,965 | $31,611 |
| 2022 | 6 | 271 | 302 | $107,730 | $32,714 |
| 2021 | 11 | 340 | 357 | $95,905 | $33,006 |
| 2020 | 13 | 376 | 412 | $94,630 | $33,467 |
Total Patients
1,268
Total Services
1,398
Medicare Billing
$130,798
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 151 | $54,360 | $16,654 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $12,040 | $4,277 | 35.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 20 | $9,820 | $3,377 | 34.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $9,860 | $3,236 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 30 | $7,350 | $2,313 | 31.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 44 | 45 | $7,390 | $1,078 | 14.6% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 34 | 37 | $3,145 | $674.64 | 21.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 60 | 60 | $34,780 | $11,912 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 94 | $33,840 | $10,176 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 35 | $20,175 | $5,812 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 42 | $10,290 | $3,125 | 30.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 56 | 58 | $7,540 | $1,436 | 19.0% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 12 | 13 | $1,105 | $251.99 | 22.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 55 | $17,545 | $6,411 | 36.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 29 | 29 | $16,040 | $6,179 | 38.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 60 | $12,920 | $4,710 | 36.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 25 | 25 | $12,570 | $4,699 | 37.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 25 | $10,745 | $4,002 | 37.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 22 | 22 | $5,720 | $1,968 | 34.4% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 33 | 33 | $6,120 | $1,801 | 29.4% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2021 | 33 | 33 | $4,680 | $1,318 | 28.2% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 24 | 25 | $3,250 | $718.66 | 22.1% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 17 | 17 | $4,140 | $652.90 | 15.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2021 | 12 | 12 | $1,440 | $384.84 | 26.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 21 | 21 | $735.00 | $163.59 | 22.3% |
About Gerald Smaldone, M.D., PHD
Gerald Smaldone, M.D., PHD is a Pulmonary Disease healthcare provider based in East Setauket, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891710828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gerald Smaldone, M.D., PHD has received a total of $335,530 in payments from pharmaceutical and medical device companies, with $42,057 received in 2022. These payments were reported across 58 transactions from 12 companies. The most common payment nature is "Royalty or License" ($187,190).
As a Medicare-enrolled provider, Smaldone has provided services to 1,268 Medicare beneficiaries, totaling 1,398 services with total Medicare billing of $130,798. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location East Setauket, NY
- Active Since 07/12/2006
- Last Updated 04/10/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1891710828
Products in Payments
- SECURE FIT MASK (Device) $70,000
- Kitabis Pak (Drug) $67,153
- AXESS LOW PROFILE NASAL MASK (Device) $10,000
- ZERBAXA (Drug) $389.93
- Esbriet (Biological) $138.99
- Xolair (Biological) $137.70
- Arikayce (Drug) $135.42
- ACTHAR (Biological) $31.40
- DUPIXENT (Biological) $23.38
- XOLAIR (Biological) $23.03
- Olympus Respiratory Accessories (Device) $21.27
- NUCALA (Biological) $18.23
- CALDOLOR (Drug) $12.94
- TRELEGY ELLIPTA (Drug) $12.40
- Caldolor (Drug) $11.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in East Setauket
Dr. Rajeev Patel, M.d, M.D
Pulmonary Disease — Payments: $25,312
Pulmonary Disease $25,312
Dr. Mohamed Mansour, M.d, M.D
Pulmonary Disease — Payments: $18,444
Pulmonary Disease $18,444
Dr. Lucy Palmer, M.d, M.D
Pulmonary Disease — Payments: $9,416
Pulmonary Disease $9,416
Dr. Thomas O'riordan, M.d, M.D
Pulmonary Disease — Payments: $1,181
Pulmonary Disease $1,181
Mohamed Sameen, Md, MD
Pulmonary Disease — Payments: $696.28
Pulmonary Disease $696.28
Dr. Paul Richman, M.d, M.D
Pulmonary Disease — Payments: $656.48
Pulmonary Disease $656.48